PDB Short entry for 1X6N HEADER HYDROLASE 11-AUG-04 1X6N TITLE CRYSTAL STRUCTURE OF S. MARCESCENS CHITINASE A MUTANT W167A IN COMPLEX TITLE 2 WITH ALLOSAMIDIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHITINASE A; COMPND 3 CHAIN: A; COMPND 4 EC: 3.2.1.14; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SERRATIA MARCESCENS; SOURCE 3 ORGANISM_TAXID: 615; SOURCE 4 GENE: CHIA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET23A KEYWDS INHIBITOR COMPLEX, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR N.N.ARONSON JR.,B.A.HALLORAN,M.F.ALEXYEV,X.E.ZHOU,Y.WANG,E.J.MEEHAN, AUTHOR 2 L.CHEN REVDAT 6 23-AUG-23 1X6N 1 REMARK REVDAT 5 13-APR-22 1X6N 1 COMPND REMARK HET HETNAM REVDAT 5 2 1 HETSYN FORMUL LINK SITE REVDAT 5 3 1 ATOM REVDAT 4 20-OCT-21 1X6N 1 SEQADV HETSYN REVDAT 3 09-NOV-16 1X6N 1 REMARK VERSN REVDAT 2 24-FEB-09 1X6N 1 VERSN REVDAT 1 26-JUL-05 1X6N 0 JRNL AUTH N.N.ARONSON JR.,B.A.HALLORAN,M.F.ALEXYEV,X.E.ZHOU,Y.WANG, JRNL AUTH 2 E.J.MEEHAN,L.CHEN JRNL TITL MUATION OF TRP167 AT THE -3 SUBSITE OF THE CHITIN-BINDING JRNL TITL 2 CLEFT OF S. MARCESCENS CHITINASE A CAUSES ENHANCED JRNL TITL 3 TRANSGLYCOSYLATION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 529978.160 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 81.5 REMARK 3 NUMBER OF REFLECTIONS : 54333 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2770 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 46.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4781 REMARK 3 BIN R VALUE (WORKING SET) : 0.2570 REMARK 3 BIN FREE R VALUE : 0.2700 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 270 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4119 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 43 REMARK 3 SOLVENT ATOMS : 185 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 7.05000 REMARK 3 B22 (A**2) : -7.28000 REMARK 3 B33 (A**2) : 0.23000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM SIGMAA (A) : 0.20 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.840 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.350 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.050 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.270 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.120 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.37 REMARK 3 BSOL : 43.36 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ALLOS.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ALLOS.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1X6N COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1000030005. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64829 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.3 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : 0.06400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 82.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.52700 REMARK 200 R SYM FOR SHELL (I) : 0.52700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1X6L REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.02 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: METHANOL,HEPES, PH 7.3, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 38.33500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 66.53500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 96.11000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 38.33500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 66.53500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 96.11000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 38.33500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 66.53500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 96.11000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 38.33500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 66.53500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 96.11000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ARG A 2 REMARK 465 LYS A 3 REMARK 465 PHE A 4 REMARK 465 ASN A 5 REMARK 465 LYS A 6 REMARK 465 PRO A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 ALA A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 ILE A 13 REMARK 465 GLY A 14 REMARK 465 SER A 15 REMARK 465 THR A 16 REMARK 465 LEU A 17 REMARK 465 CYS A 18 REMARK 465 SER A 19 REMARK 465 ALA A 20 REMARK 465 ALA A 21 REMARK 465 GLN A 22 REMARK 465 ALA A 23 REMARK 465 GLN A 563 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 316 N - CA - C ANGL. DEV. = 17.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 45 -7.58 -58.97 REMARK 500 GLU A 147 -130.33 45.34 REMARK 500 TYR A 170 -106.19 -91.77 REMARK 500 PHE A 191 108.29 71.26 REMARK 500 LYS A 250 -152.24 -120.40 REMARK 500 PHE A 316 102.83 72.36 REMARK 500 THR A 405 30.72 -145.76 REMARK 500 LYS A 413 71.05 -161.75 REMARK 500 GLU A 500 62.22 67.31 REMARK 500 GLU A 540 102.26 51.95 REMARK 500 ALA A 560 -135.12 -83.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: OLIGOSACCHARIDE INHIBITOR REMARK 630 MOLECULE NAME: ALLOSAMIZOLINE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 AMI A 601 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: NULL REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AO3 A 564 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1RD6 RELATED DB: PDB REMARK 900 CHITINASE A MUTANT W167A STRUCTURE AT 2.6A WITHOUT THE INHIBITOR REMARK 900 RELATED ID: 1X6L RELATED DB: PDB REMARK 900 CHITINASE A MUTANT W167A STRUCTURE AT 1.9A WITHOUT THE INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS VERIFIED THE SEQUENCE BY MS AND DNA SEQUENCING. DBREF 1X6N A 1 563 UNP P07254 CHIA_SERMA 1 563 SEQADV 1X6N PRO A 139 UNP P07254 ALA 139 SEE REMARK 999 SEQADV 1X6N SER A 144 UNP P07254 PRO 144 SEE REMARK 999 SEQADV 1X6N ALA A 167 UNP P07254 TRP 167 ENGINEERED MUTATION SEQADV 1X6N ILE A 226 UNP P07254 VAL 226 SEE REMARK 999 SEQADV 1X6N ALA A 395 UNP P07254 PRO 395 SEE REMARK 999 SEQADV 1X6N ILE A 437 UNP P07254 VAL 437 SEE REMARK 999 SEQADV 1X6N GLU A 473 UNP P07254 LYS 473 SEE REMARK 999 SEQADV 1X6N SER A 484 UNP P07254 GLY 484 SEE REMARK 999 SEQRES 1 A 563 MET ARG LYS PHE ASN LYS PRO LEU LEU ALA LEU LEU ILE SEQRES 2 A 563 GLY SER THR LEU CYS SER ALA ALA GLN ALA ALA ALA PRO SEQRES 3 A 563 GLY LYS PRO THR ILE ALA TRP GLY ASN THR LYS PHE ALA SEQRES 4 A 563 ILE VAL GLU VAL ASP GLN ALA ALA THR ALA TYR ASN ASN SEQRES 5 A 563 LEU VAL LYS VAL LYS ASN ALA ALA ASP VAL SER VAL SER SEQRES 6 A 563 TRP ASN LEU TRP ASN GLY ASP ALA GLY THR THR ALA LYS SEQRES 7 A 563 ILE LEU LEU ASN GLY LYS GLU ALA TRP SER GLY PRO SER SEQRES 8 A 563 THR GLY SER SER GLY THR ALA ASN PHE LYS VAL ASN LYS SEQRES 9 A 563 GLY GLY ARG TYR GLN MET GLN VAL ALA LEU CYS ASN ALA SEQRES 10 A 563 ASP GLY CYS THR ALA SER ASP ALA THR GLU ILE VAL VAL SEQRES 11 A 563 ALA ASP THR ASP GLY SER HIS LEU PRO PRO LEU LYS GLU SEQRES 12 A 563 SER LEU LEU GLU LYS ASN LYS PRO TYR LYS GLN ASN SER SEQRES 13 A 563 GLY LYS VAL VAL GLY SER TYR PHE VAL GLU ALA GLY VAL SEQRES 14 A 563 TYR GLY ARG ASN PHE THR VAL ASP LYS ILE PRO ALA GLN SEQRES 15 A 563 ASN LEU THR HIS LEU LEU TYR GLY PHE ILE PRO ILE CYS SEQRES 16 A 563 GLY GLY ASN GLY ILE ASN ASP SER LEU LYS GLU ILE GLU SEQRES 17 A 563 GLY SER PHE GLN ALA LEU GLN ARG SER CYS GLN GLY ARG SEQRES 18 A 563 GLU ASP PHE LYS ILE SER ILE HIS ASP PRO PHE ALA ALA SEQRES 19 A 563 LEU GLN LYS ALA GLN LYS GLY VAL THR ALA TRP ASP ASP SEQRES 20 A 563 PRO TYR LYS GLY ASN PHE GLY GLN LEU MET ALA LEU LYS SEQRES 21 A 563 GLN ALA HIS PRO ASP LEU LYS ILE LEU PRO SER ILE GLY SEQRES 22 A 563 GLY TRP THR LEU SER ASP PRO PHE PHE PHE MET GLY ASP SEQRES 23 A 563 LYS VAL LYS ARG ASP ARG PHE VAL GLY SER VAL LYS GLU SEQRES 24 A 563 PHE LEU GLN THR TRP LYS PHE PHE ASP GLY VAL ASP ILE SEQRES 25 A 563 ASP TRP GLU PHE PRO GLY GLY LYS GLY ALA ASN PRO ASN SEQRES 26 A 563 LEU GLY SER PRO GLN ASP GLY GLU THR TYR VAL LEU LEU SEQRES 27 A 563 MET LYS GLU LEU ARG ALA MET LEU ASP GLN LEU SER ALA SEQRES 28 A 563 GLU THR GLY ARG LYS TYR GLU LEU THR SER ALA ILE SER SEQRES 29 A 563 ALA GLY LYS ASP LYS ILE ASP LYS VAL ALA TYR ASN VAL SEQRES 30 A 563 ALA GLN ASN SER MET ASP HIS ILE PHE LEU MET SER TYR SEQRES 31 A 563 ASP PHE TYR GLY ALA PHE ASP LEU LYS ASN LEU GLY HIS SEQRES 32 A 563 GLN THR ALA LEU ASN ALA PRO ALA TRP LYS PRO ASP THR SEQRES 33 A 563 ALA TYR THR THR VAL ASN GLY VAL ASN ALA LEU LEU ALA SEQRES 34 A 563 GLN GLY VAL LYS PRO GLY LYS ILE VAL VAL GLY THR ALA SEQRES 35 A 563 MET TYR GLY ARG GLY TRP THR GLY VAL ASN GLY TYR GLN SEQRES 36 A 563 ASN ASN ILE PRO PHE THR GLY THR ALA THR GLY PRO VAL SEQRES 37 A 563 LYS GLY THR TRP GLU ASN GLY ILE VAL ASP TYR ARG GLN SEQRES 38 A 563 ILE ALA SER GLN PHE MET SER GLY GLU TRP GLN TYR THR SEQRES 39 A 563 TYR ASP ALA THR ALA GLU ALA PRO TYR VAL PHE LYS PRO SEQRES 40 A 563 SER THR GLY ASP LEU ILE THR PHE ASP ASP ALA ARG SER SEQRES 41 A 563 VAL GLN ALA LYS GLY LYS TYR VAL LEU ASP LYS GLN LEU SEQRES 42 A 563 GLY GLY LEU PHE SER TRP GLU ILE ASP ALA ASP ASN GLY SEQRES 43 A 563 ASP ILE LEU ASN SER MET ASN ALA SER LEU GLY ASN SER SEQRES 44 A 563 ALA GLY VAL GLN HET NAA B 1 14 HET NAA B 2 14 HET AMI A 601 15 HETNAM NAA 2-ACETAMIDO-2-DEOXY-BETA-D-ALLOPYRANOSE HETNAM AMI ALLOSAMIZOLINE HETSYN NAA N-ACETYL-BETA-D-ALLOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA-D- HETSYN 2 NAA ALLOSE; 2-ACETAMIDO-2-DEOXY-D-ALLOSE; 2-ACETAMIDO-2- HETSYN 3 NAA DEOXY-ALLOSE; N-ACETYL-D-ALLOSAMINE FORMUL 2 NAA 2(C8 H15 N O6) FORMUL 3 AMI C9 H16 N2 O4 FORMUL 4 HOH *185(H2 O) HELIX 1 1 ALA A 49 LEU A 53 1 5 HELIX 2 2 VAL A 165 TYR A 170 5 6 HELIX 3 3 THR A 175 ILE A 179 5 5 HELIX 4 4 PRO A 180 LEU A 184 5 5 HELIX 5 5 ASN A 201 ILE A 207 5 7 HELIX 6 6 GLY A 209 CYS A 218 1 10 HELIX 7 7 ASP A 230 GLN A 236 1 7 HELIX 8 8 LYS A 250 HIS A 263 1 14 HELIX 9 9 SER A 278 MET A 284 5 7 HELIX 10 10 ASP A 286 TRP A 304 1 19 HELIX 11 11 GLN A 330 GLY A 354 1 25 HELIX 12 12 GLY A 366 ASP A 371 1 6 HELIX 13 13 ALA A 374 GLN A 379 1 6 HELIX 14 14 ASN A 380 MET A 382 5 3 HELIX 15 15 THR A 419 GLY A 431 1 13 HELIX 16 16 LYS A 433 GLY A 435 5 3 HELIX 17 17 ILE A 458 GLY A 462 5 5 HELIX 18 18 TYR A 479 PHE A 486 1 8 HELIX 19 19 ASP A 517 LYS A 531 1 15 HELIX 20 20 GLU A 540 ASP A 544 5 5 HELIX 21 21 GLY A 546 LEU A 556 1 11 SHEET 1 A 3 THR A 30 ILE A 31 0 SHEET 2 A 3 ALA A 60 ASN A 67 -1 O ASN A 67 N THR A 30 SHEET 3 A 3 SER A 95 VAL A 102 -1 O ALA A 98 N VAL A 64 SHEET 1 B 5 LYS A 37 ALA A 39 0 SHEET 2 B 5 THR A 126 ALA A 131 1 O VAL A 129 N PHE A 38 SHEET 3 B 5 GLY A 106 ASN A 116 -1 N MET A 110 O THR A 126 SHEET 4 B 5 THR A 76 LEU A 81 -1 N THR A 76 O CYS A 115 SHEET 5 B 5 LYS A 84 PRO A 90 -1 O GLY A 89 N ALA A 77 SHEET 1 C 4 LYS A 37 ALA A 39 0 SHEET 2 C 4 THR A 126 ALA A 131 1 O VAL A 129 N PHE A 38 SHEET 3 C 4 GLY A 106 ASN A 116 -1 N MET A 110 O THR A 126 SHEET 4 C 4 GLY A 119 ALA A 122 -1 O THR A 121 N LEU A 114 SHEET 1 D 2 VAL A 41 VAL A 43 0 SHEET 2 D 2 VAL A 54 VAL A 56 -1 O LYS A 55 N GLU A 42 SHEET 1 E 9 VAL A 159 PHE A 164 0 SHEET 2 E 9 HIS A 186 ILE A 192 1 O GLY A 190 N PHE A 164 SHEET 3 E 9 LYS A 267 GLY A 273 1 O LYS A 267 N LEU A 187 SHEET 4 E 9 GLY A 309 ASP A 313 1 O ASP A 313 N ILE A 272 SHEET 5 E 9 GLU A 358 SER A 364 1 O THR A 360 N ILE A 312 SHEET 6 E 9 HIS A 384 MET A 388 1 O PHE A 386 N SER A 361 SHEET 7 E 9 ILE A 437 ALA A 442 1 O VAL A 438 N ILE A 385 SHEET 8 E 9 GLY A 535 TRP A 539 1 O PHE A 537 N THR A 441 SHEET 9 E 9 VAL A 159 PHE A 164 1 N VAL A 159 O LEU A 536 SHEET 1 F 3 GLY A 466 PRO A 467 0 SHEET 2 F 3 TYR A 444 THR A 449 -1 N THR A 449 O GLY A 466 SHEET 3 F 3 ILE A 476 ASP A 478 -1 O VAL A 477 N GLY A 445 SHEET 1 G 5 GLY A 466 PRO A 467 0 SHEET 2 G 5 TYR A 444 THR A 449 -1 N THR A 449 O GLY A 466 SHEET 3 G 5 ASP A 511 THR A 514 -1 O THR A 514 N ARG A 446 SHEET 4 G 5 ALA A 501 LYS A 506 -1 N LYS A 506 O ASP A 511 SHEET 5 G 5 GLN A 492 ASP A 496 -1 N GLN A 492 O PHE A 505 SSBOND 1 CYS A 115 CYS A 120 1555 1555 2.04 SSBOND 2 CYS A 195 CYS A 218 1555 1555 2.05 LINK O4 AMI A 601 C1 NAA B 1 1555 1555 1.39 LINK O4 NAA B 1 C1 NAA B 2 1555 1555 1.37 SITE 1 AC1 16 TYR A 163 PHE A 191 TRP A 275 THR A 276 SITE 2 AC1 16 ASP A 313 GLU A 315 MET A 388 TYR A 390 SITE 3 AC1 16 ASP A 391 TYR A 444 ARG A 446 GLU A 473 SITE 4 AC1 16 ILE A 476 TRP A 539 GLU A 540 HOH A 728 CRYST1 76.670 133.070 192.220 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013043 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007515 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005202 0.00000